Search Results - "Throm, Richard C"

Naked plasmid DNA encoding fibroblast growth factor type 1 for the treatment of end-stage unreconstructible lower extremity ischemia: Preliminary results of a phase I trial by Comerota, Anthony J., Throm, Richard C., Miller, Kathryn A., Henry, Timothy, Chronos, Nicolas, Laird, John, Sequeira, Rafael, Kent, Craig K., Bacchetta, Matthew, Goldman, Corey, Salenius, Juha-Pekka, Schmieder, Frank A., Pilsudski, Richard

“…Objective: The objective of this study was to evaluate the safety and tolerance of increasing single and repeated (n = 2) doses of intramuscular naked plasmid…”
Get full text

Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life by Comerota, Anthony J., Throm, Richard C., Mathias, Susan D., Haughton, Signe, Mewissen, Mark

“…Purpose: Treatment designed to eliminate thrombus in patients with iliofemoral deep venous thrombosis (DVT) is theoretically attractive; however, its benefits,…”
Get full text

Managing PAD with multiple platelet inhibitors: the effect of combination therapy on bleeding time by Wilhite, Douglas B, Comerota, Anthony J, Schmieder, Frank A, Throm, Richard C, Gaughan, John P, Koneti Rao, A

“…Patients with lower-extremity peripheral arterial disease (PAD) face a high risk of cardiovascular morbidity and mortality. Platelet inhibition (PI)…”
Get full text

Tissue (muscle) oxygen saturation (StO 2): A new measure of symptomatic lower-extremity arterial disease by Comerota, Anthony J, Throm, Richard C, Kelly, Patrick, Jaff, Michael

“…Near-infrared spectroscopy provides a noninvasive method of measuring tissue oxygen saturation and has been used to monitor extremity compartment syndrome…”
Get full text

A health-related quality of life measure in patients with deep vein thrombosis : A validation study by MATHIAS, S. D, PREBIL, L. A, PUTTERMAN, C. G, CHMIEL, J. J, THROM, R. C, COMEROTA, A. J

Get full text

A prospective, randomized, blinded, and placebo-controlled trial of intraoperative intra-arterial urokinase infusion during lower extremity revascularization. Regional and systemic effects by Comerota, A J, Rao, A K, Throm, R C, Skibinski, C I, Beck, G J, Ghosh, S, Sun, L, Curl, G R, Ricotta, J J, Graor, R A

“…This study was designed to evaluate the safety and regional and systemic effects of three doses of urokinase (UK) infused into the distal arterial circulation…”
Get full text